|
|
|||||||||
Basic Science Investigations |
1 Department of Radiology, The University of Arizona, Tucson, Arizona
2 Molecular Targeting Technologies Inc., West Chester, Pennsylvania
| ABSTRACT |
|---|
|
|
|---|
Key Words: 99mTc-glucarate ischemiareperfusion injury rat heart high-resolution SPECT
| INTRODUCTION |
|---|
|
|
|---|
To date, few studies have been done regarding 99mTc-GLA imaging in ischemicreperfused myocardium with varied severity of injury. This study was conducted to determine whether the amount of myocardial damage in the hearts with ischemiareperfusion is associated with myocardial accumulation levels of 99mTc-GLA. It is not known whether this association is reflected in the degree of myocardial injury in the ischemicreperfused hearts. First, severity of injury can be estimated by the size of infarct or amount of irreversible myocytic necrosis. In clinical patients, infarct size can be determined with several noninvasive techniques, which has significance for general prognosis in patients after acute heart attack. Since 99mTc-GLA is accumulated by acute necrotic myocardium only, we speculated that 99mTc-GLA hot spot imaging might be ideal for noninvasively determining infarct size with a SPECT camera. Using well-defined in vivo rat heart models, we acquired 99mTc-GLA images with a novel high-resolution stationary SPECT system called FASTSPECT. Ischemiareperfusion injury was analyzed by triphenyltetrazolium chloride (TTC) staining and electron microscope examination. We quantified and compared the infarct size shown by 99mTc-GLA imaging with the TTC staining analysis. Second, since the uptake and washout kinetics of viability-dependent imaging agents are altered by the extent and severity of cellular and extracellular structural changes of ischemicreperfused myocardium, the present study was undertaken to determine the in vivo kinetic properties of 99mTc-GLA for assessing the severity of myocardial ischemiareperfusion injury in rat heart models exposed to different durations of left coronary artery (LCA) occlusion with reperfusion. Using FASTSPECT, dynamic tomographic images were obtained in the beating rat hearts with no motion of detectors or imaging aperture. We wanted to clarify whether a rapid sequence of 3-dimensional (3D) imaging with FASTSPECT can make it possible to visualize the heart with ischemiareperfusion injury and investigate the kinetics of cardiovascular imaging agents in small-animal in vivo models.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Experimental Groups and Study Protocols
Eighteen rats were divided into 2 groups to receive regional myocardial ischemiareperfusion treatments. Group 1 animals (IR30, n = 12 [IR = ischemiareperfusion]) were treated by ligating the LCA for 30 min and releasing the ligature for 30 min. The LCA in group 2 animals (IR90, n = 6) was ligated for 90 min and then released for 30 min. The experimental protocols are showed in Figure 1.
|
FASTSPECT System
The high-resolution stationary SPECT system, FASTSPECT, was built in the Department of Radiology Research Laboratory at The University of Arizona (911). In this system, 24 small modular
-cameras are arranged in 2 circular arrays with a cylindric aperture. Each modular camera possesses a 10 x 10 cm Rexon NaI(Tl) scintillation crystal (Rexon Components, Inc.), an optical light guide, 4 square (5 x 5 cm) Hamamatsu Photonics photomultiplier tubes, and driver/amplifier electronics. Twenty-four 1-mm-diameter pinholes were drilled in the aperture such that a point source in the center of the field of view (FOV) is simultaneously projected to the center of each camera. The dead space between adjacent cameras at the director surface is <7% of the total area. The total magnification is 3.5 in a 3.0 x 3.2 x 3.2 cm FOV. The spatial resolution of the system is about 1.0 mm with a sensitivity of 0.359 cps/kBq (13.3 cps/µCi) in air.
FASTSPECT Imaging
The rat was placed inside the aperture using a 6-cm-diameter cylindric cardboard holder mounted on a translation stage. The animal was positioned so that the heart localized in the center of the FOV. Thirty minutes after LCA reflow, 99mTc-GLA (148296 MBq [48 mCi]) was injected as a bolus via the jugular vein catheter, followed by a 0.2-mL saline flush. Dynamic images were acquired every 1 min for 10 min beginning immediately on injection, followed by 5-min acquisitions at 15, 20, and 30 min. Then 5-min images were obtained every 15 min from 30 to 120 min after injection. A total of 24 projections were obtained, one from each camera. Each projection image was formed using a 24-bit word as an entry to a precomputed look-up table scheme. In this scheme, each scintillation event within the NaI crystal of the camera was registered as the digitized outputs from the cameras 4 photomultiplier tubes. To estimate energy and interaction position, the 4 outputs were then compared with the 20-bit look-up table. This table was precalculated using a calibration procedure that involved moving a collimated source across the camera face (12).
Image Processing
The maximum-likelihood expectation-maximization reconstruction algorithm was applied to generate 3D images. All images were reconstructed using 100 iterations. Using SlicerDicer software (PIXOTEC LLC), 3D images were computed to provide images in a 33 x 49 x 49 voxels format, reoriented manually regarding the cardiac axis. Then serial tomographic short-axis, vertical, and horizontal long-axis slices of the heart with 1-pixel thickness (1.0 mm) were generated.
A region of interest (ROI) was established over a hot spot with the highest activity of 99mTc-GLA (counts/pixel) selected from a short-axis slice of the 120-min image. The ROI was applied to all images from 1 to 120 min after injection. After correction for background and 99mTc decay, the radioactivity (counts/pixel/min) in the hot spot was projected onto the dynamic images to determine the timeactivity curve. Using an ROI selected from the non-LCA region (left ventricular septum), the normal myocardial timeactivity curve was generated and compared with the curve of the infarct zone. Hot spots on all short-axis slices of 120-min image were quantified with ROI analysis to calculate the ratios of necrotic zone activities to normal myocardial activities and averaged over the whole heart to produce a mean ratio.
Measurement of Myocardial Risk and Infarct
After imaging acquisition was completed, the animal was moved out of the aperture. The chest of the rat was reopened and the LCA was reoccluded using the same ligature. To determine the myocardial ischemic area at risk (IAR), 1.0 mL Evans blue (20%) in phosphate-buffered saline (PBS) was injected through the femoral vein, allowing dye to stain the nonischemic portion of the heart. The risk zone was identified as that region lacking blue staining. An overdose injection of pentobarbital was followed immediately to kill the animal. The entire heart was expeditiously excised, weighed, and rinsed of excess dye with cold saline. 99mTc activity in the heart was measured in a CRC-4 radioisotope dose calibrator (Capintec). The great vessels, atria, and right ventricle of the heart were removed. The left ventricle was sectioned into 4 transverse slices in a plane parallel to the atrioventricular groove. Both sides of each tissue slice were photographed immediately using a D-500L digital camera (Olympus Optical Co.).
TTC staining was used to identify the area with infarct. The tissue slices were incubated in 1% TTC PBS solution (pH = 7.4) at 37°C for 20 min and subsequently fixed in 10% PBS-buffered formalin overnight at 2°C8°C. The viable myocardium stained by TTC was dark red. Both sides of each TTC-stained tissue slice were photographed again with the digital camera.
The IAR (unstained by Evans blue dye) and the TTC-negative area (white or pale, necrotic myocardium) on the digital photographs were outlined and quantified using the SigmaScan software (SPSS Science) in trace-measurement mode. Infarct size was expressed both as a percentage of total LV mass (% LV) and as a percentage of the IAR (% IAR).
Determination of Infarct on FASTSPECT Imaging
The hot spot size of 99mTc-GLA on the 120-min image was determined on short-axis slices using the trace-measurement mode of SigmaScan software as described. The left ventricular wall was outlined using the 1-min cardiac blood-pool image as a contrast. The size of hot spots on short-axis slices were averaged as a percentage of the entire left ventricle and then normalized to the percentage of the IAR (% IAR).
Assessment of Ultrastructural Injury
An additional 4 rats were subjected to the experimental protocol without radiotracer administration. Two rat hearts were treated as the IR30 protocol in group 1; others were treated as the IR90 protocol in group 2. After a 30-min reperfusion, 0.5 mL saline was intravenously injected to match the injected volume of 99mTc-GLA and saline in group 1 and group 2. The anesthetized rats were kept alive under the same experimental conditions as described for 2 h and then killed at the end of the experiment. Two small blocks of left ventricular tissue were selected from the LCA ischemicreperfused central area and nonischemic area (septum) of each heart, respectively. The tissue blocks were immersed in a phosphate-buffered 3% glutaraldehyde solution (pH 7.4) for 3 h at 4°C. Then the samples were transferred and postfixed in 1% osmium tetroxide, dehydrated in a graded series of ethanol, and embedded in epoxy resin. Ultrathin sections were stained with uranyl acetate and lead hydroxide and examined with a transmission electron microscope ([TEM] Phillips CM12).
Data Analysis
All results are expressed as mean ± SEM. Comparisons between groups were performed with 1-way ANOVA. Comparisons between 2 variables within a group were made using a paired t test. Probability values < 0.05 were considered significant. The correlation between myocardial 99mTc-GLA hot spots and myocardial infarct size as measured by TTC stain was assessed by linear regression analysis.
Hot spot and normal zone activities were normalized to peak activities at 2 min for each experiment and averaged for the group to produce mean myocardial timeactivity washout curves. The kinetic washout curves of 99mTc-GLA were fit with nonlinear regression procedures using TableCurve 2-dimensional software (Systat Software, Inc.).
Ethics
All experiments were performed in accordance with the animal research guidelines of the National Research Council (13) and were approved by the Institutional Animal Care and Use Committee at The University of Arizona.
| RESULTS |
|---|
|
|
|---|
|
|
|
Myocardial IAR and Infarct Size
The measurements of myocardial ischemic IAR and infarct are shown in Table 1. The difference of myocardial ischemic IARs as shown by lack of Evans blue between the hearts subjected to 30- and 90-min LCA occlusion was not significant. The 99mTc-GLA hot spots on FASTSPECT images were consistent with the unstained areas on TTC staining (Figs. 5A and 5B). The percent infarct size of left ventricles measured by TTC staining in group 1 was significantly smaller than that of group 2. Normalized by the ischemic IAR, the infarct size (% IAR) in group 1 was still significantly smaller than that of group 2. The quantified hot spots with 99mTc-GLA on FASTSPECT imaging represented a good agreement with the infarct measurements on TTC staining. The hearts subjected to 90-min LCA occlusion exhibited significantly larger hot spots compared with the hearts subjected to 30-min LCA occlusion (P < 0.05). There was a significant correlation between the infarct measurements (corrected by IAR, % IAR) with TTC staining and 99mTc-GLA FASTSPECT imaging in either group 1 (r = 0.797, P = 0.0019) or group 2 (r = 0.956, P = 0.0029). Figure 6 illustrates the overall correlation between the measurements in all 18 experimental hearts (r = 0.912, P < 0.0001).
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
99mTc-GLA has been tested in a variety of animal models to investigate its infarct-avid localizing properties, including ex vivo isolated perfused rat and rabbit hearts and in vivo rabbit, canine, and swine heart models (2,3,14,15). Using a swine model with myocardial ischemia induced by a catheter-mounted stenosis in the left anterior descending coronary artery, Johnson et al. reported positive uptake of 99mTc-GLA in the severe ischemic myocardium (15). Of the 15 99mTc-GLA scan-positive studies, 8 animals showed scattered TTC-negative staining in the IAR. Electron microscope analysis demonstrated focal irreversible myocyte injury characterized by flocculent densities within mitochondria from the risk region with 99mTc-GLA scan-positive and TTC-positive staining. 99mTc-GLA was sensitive enough to be able to detect early mild scattered myocardial infarcts and micronecroses. Obviously, TTC staining might not delineate myocyte injury in detail and neglect micronecroses. Thus, we assessed regional myocardial injury in the ischemicreperfused rat heart models using both TTC staining and TEM analysis.
Beanlands et al. used a 15-min global ischemia with a complete reperfusion rat heart model in comparison with 90-min ischemia (14). Significantly higher myocardial retention of 99mTc-GLA was found in the 90-min ischemia model but not in the 15-min ischemia model. Effluent creatine kinase (CK) measurement demonstrated that 90 min of flow interruption was sufficient to induce myocardial necrosis, whereas 15 min was not. It was reported that the TTC-negative area might contain approximately 13% reversible injury in an LCA occlusion rat model with 20-min ischemia (16). After 20 min of ischemia, myocardial infarct is markedly increased and further exacerbated by reperfusion. With 30 min of coronary occlusion, the necrotic area can be clearly delineated within the myocardium with the TTC staining technique. Therefore, to investigate in vivo kinetic properties of 99mTc-GLA for assessing the severity of myocardial ischemiareperfusion injury, we selected rat heart models with 30- and 90-min LCA occlusion followed by reperfusion and compared the severities of irreversible necrosis. As a result, the radioactivities and sizes of 99mTc-GLA hot spots were significantly distinguishable between the hearts subjected to different durations of ischemia. The high avidity of 99mTc-GLA for the infarct makes its uptake visualizable within 10 min after intravenous administration. Forty-five minutes after injection, the ratios of hot spots to normal zone radioactivities showed a significant difference between the 30- and 90-min ischemia heart models.
Few previous studies specifically determined myocardial washout kinetics of 99mTc-GLA in vivo. The results of our study show that 30 min of LCA occlusion followed by a 30-min reperfusion induces a significantly slower washout of 99mTc-GLA in the necrotic myocardium compared with that of the normal myocardial zone. The kinetic alteration of 99mTc-GLA is markedly accelerated by 90-min LCA occlusion. A biexponential function was found to be the best fit for describing the washout pattern of 99mTc-GLA. A rapid early clearance phase followed by a slow second phase was observed in the ischemicreperfused myocardium and normal zone. In the early phase, which mainly reflects blood perfusion and effusion, the t1/2 of 99mTc-GLA from the biexponential function did not differ between the infarct and normal zones. In the second phase, which reflects cellular efflux of 99mTc-GLA, the t1/2 of the hot spot was significantly longer than that in the normal myocardium. The principal differences among the hearts subjected to 30- and 90-min ischemia resulted from a differential late phase washout. The longer t1/2 or slow clearance in the second phase was more pronounced in 90-min ischemic hearts. These data indicate that the severity of myocardial injury induced by different durations of ischemia with reperfusion in rat heart models can be quantitatively analyzed with 99mTc-GLA dynamic imaging using the fast acquisition capability of FASTSPECT.
Using FASTSPECT imaging, our previous study has demonstrated that the infarct size can be quantitatively measured in rat heart models with 99mTc-sestamibi defects (9). 99mTc-Sestamibi myocardial activity correlates the amount of viable myocardium stained by TTC. The extent of the left ventricular perfusion defect on 99mTc-sestamibi images reflects the size of the myocardial infarction. 99mTc-GLA is accumulated by infracted tissue only. The results of the present study indicate that hot spot imaging with 99mTc-GLA is promising for the determination of infarct size in persistently occluded or reperfused myocardial infarcts. Measurement of FASTSPECT imaging demonstrated that the hot spot size of 99mTc-GLA correlates well with the infarct size determined by TTC staining. In comparison with 99mTc-sestambi imaging, in which the defects are clearly contrasted with normal myocardium, negative accumulation of 99mTc-GLA in normal myocardium makes the quantitative analysis difficult to calculate the percentage of infarct over the whole left ventricle in the heart with a small- size infarct. We used the early blood-pool image to identify the left ventricular wall range so that the percentage of infarct size could be quantified in the present study. Using a computed 3D display, absolute infarct volume may be measured more reliably, which provides insight into prognosis after acute myocardial infarction.
To our knowledge, the in vivo kinetics of cardiovascular radiopharmaceuticals have not been investigated previously with dynamic high-resolution SPECT imaging in rat heart models. Large animals, such as canines, are often used for in vivo experimental imaging in coronary artery disease. However, the cost for large animals is high, and experience with surgical techniques is required. The small-animal heart model, such as rodents, offers advantages over large-animal models, such as low cost, simple procedures in surgery, and a high successful rate in modeling. In addition, many gene therapy strategies for the treatment of cardiac failure and long-term myocardial protection are being studied in rodent models with noninvasive imaging requirement. In recent years, high-resolution tomographic imaging systems have become available for small-animal studies in basic biomedical science so that many experimental procedures in large-animal cardiac models can be performed in rat models (17). In our rat heart models of the present study, dynamic cardiac images were acquired with FASTSPECT using procedures similar to those required by clinical physicians. But tomographic dynamic imaging cannot be achieved by a regular clinical rotating SPECT camera. With the advantages of FASTSPECT, the myocardial radioactivity in the present study could be quantified accurately and the washout kinetics of 99mTc-GLA were determined effectively. The quantitative analysis of myocardial infarct on tomographic images showed a significant correlation with biochemical staining measurement.
| CONCLUSION |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
For correspondence or reprints contact: Zhonglin Liu, MD, Department of Radiology, The University of Arizona, P.O. Box 245067, Tucson, AZ 85724-5067.
E-mail: zliu{at}radiology.arizona.edu
| REFERENCES |
|---|
|
|
|---|
Related articles in JNM:
This article has been cited by other articles:
![]() |
B. L. Franc, P. D. Acton, C. Mari, and B. H. Hasegawa Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation J. Nucl. Med., October 1, 2008; 49(10): 1651 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fonge, K. Vunckx, H. Wang, Y. Feng, L. Mortelmans, J. Nuyts, G. Bormans, A. Verbruggen, and Y. Ni Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I]iodohypericin {micro}SPECT Eur. Heart J., January 2, 2008; 29(2): 260 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. McVeigh Emerging Imaging Techniques Circ. Res., April 14, 2006; 98(7): 879 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Maskali, P. R. Franken, S. Poussier, N. Tran, C. Vanhove, H. Boutley, H. Le Gall, G. Karcher, F. Zannad, P. Lacolley, et al. Initial Infarct Size Predicts Subsequent Cardiac Remodeling in the Rat Infarct Model: An In Vivo Serial Pinhole Gated SPECT Study J. Nucl. Med., February 1, 2006; 47(2): 337 - 344. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |